10-K/A: TRxADE HEALTH, INC. Files Amendment to 2023 Annual Report

TRxADE HEALTH, INC. has filed an amendment to its 2023 annual report on Form 10-K/A to include previously omitted information and updated certifications.

Summary

• TRxADE HEALTH, INC. filed an amendment to its annual report on Form 10-K/A for the year ended December 31, 2023.
• This amendment, filed on May 3, 2024, includes information previously omitted from the original filing on April 22, 2024.
• The amendment provides information required by Items 10, 11, 12, 13, and 14 of Part III of Form 10-K, which were initially omitted in reliance on General Instruction G(3) to Form 10-K.
• The filing also includes updated certifications from the principal executive officer and principal financial officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
• The company has restated Part III of the original filing in its entirety.
• The amendment does not include any financial statements or amend any disclosures related to Items 307 and 308 of Regulation S-K.
• The document also includes a cautionary statement regarding forward-looking information.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, with no significant positive or negative news. The need for an amendment is a minor negative, but the company has taken steps to rectify the situation.

Positives

• The company has taken steps to rectify omissions in its original filing.
• The updated certifications from the CEO and CFO provide assurance regarding the accuracy of the report.
• The company has provided additional information regarding directors, executive compensation, security ownership, related transactions, and accounting fees.

Negatives

• The need for an amendment suggests potential oversights in the initial filing process.
• The omission of Part III information in the original filing could raise concerns about internal controls.
• The document highlights the company's history of operating losses and potential risks.

Risks

• The document mentions risks related to operating losses, intellectual property claims, website issues, acquisition strategies, and regulatory changes.
• There are risks associated with the opioid crisis, healthcare fraud, and economic conditions.
• The company faces risks related to privacy laws, system errors, and dependence on current management.
• The document also highlights risks related to the company's growth strategy and competition.

Future Outlook

The document contains forward-looking statements regarding the company's future performance and financial condition, which are subject to risks and uncertainties.

Management Comments

• The CEO and CFO have certified that the report does not contain any untrue statements of material fact.
• Management has acknowledged the risks and uncertainties associated with forward-looking statements.

Industry Context

This filing is a standard regulatory requirement for publicly traded companies and does not indicate any specific industry trends or competitive pressures beyond those already disclosed in the original filing.

Comparison to Industry Standards

• The filing of a 10-K/A is not unusual when errors or omissions are discovered in the original 10-K filing.
• The company's actions are consistent with standard SEC reporting requirements.
• The company's corporate governance structure, including an audit committee with independent directors, is in line with industry best practices.
• The company's executive compensation practices are similar to those of other publicly traded companies of similar size and complexity.

Corporate Governance

Related Party Transactions

• The company has disclosed a consulting agreement with Scietech, LLC, where a 31% investor is the spouse of the interim CFO, Prashant Patel.
• The company issued a promissory note to Danam Health, Inc. for $300,000.
• Trxade, Inc. entered into a Subscription Agreement with Lafayette Energy Corp. to invest up to $5.0 million.

Stakeholder Impact

• Shareholders are provided with more complete information about the company's operations and financial condition.
• Employees are subject to the company's code of ethics and insider trading policies.
• The company's actions may impact its relationships with customers, suppliers, and creditors.

Next Steps

• The company will continue to file periodic reports with the SEC.
• The company will monitor and address the risks and uncertainties outlined in the document.

Key Dates

Keywords

Form 10-K/A, amendment, annual report, financial reporting, executive compensation, corporate governance, risk factors, Sarbanes-Oxley Act, directors, stock ownership